Facebook
Twitter

Home
About
- Our Team
- Careers
News
Contact

Products
Services
- Mass Spectrometric Imaging
Technology
Resources
Menu Menu

AmberGen wins Illumina’s VeraCode™ Assay Design Challenge for development of a multiplex colorectal cancer diagnostic

February 2011/in MAKING A DIFFERENCE, News /by Kenneth Rothschild

Share this entry

Share on Facebook
Share on Twitter
Share on WhatsApp
Share on LinkedIn
Share on Tumblr
Share by Mail

https://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild https://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2011-02-27 13:48:542016-11-10 12:44:59AmberGen wins Illumina’s VeraCode™ Assay Design Challenge for development of a multiplex colorectal cancer diagnostic

Menu

Home
About
Technology
Diagnostics
Therapeutics

Products
Services
Resources
News
Contact

Get in Touch

AmberGen, Inc.

313 Pleasant St.

Watertown, MA 02472

(617) 923-9990

Recent News

Recent Posts

AmberGen announces that Dr. Michael Easterling, PhD will join Board of Directors April 2022
AmberGen Announces New Appointments for John Gillespie & Dr. Kenneth J. Rothschild April 2022
AmberGen and Bruker Collaborate on Spatial Biology Imaging Reagents for MALDI-Immunohistochemistry (MALDI-IHC) April 2022
Dr. Mark Lim of AmberGen was honored to be an invited keynote speaker at the “Innovation in Mass Spectrometry Imaging Omics” Session March 2022

© 2022 - AmberGen Inc. Website designed in Massachusetts

Scroll to top